Former WHO scientist Dr Soumya Swaminathan has warned that rising pollution in North India poses serious health risks to ...

KARI's multimodal imaging dataset reveals critical insights into Alzheimer's disease, linking amyloid, tau, and brain ...

In a cross-sectional study of 59 people with asymptomatic moyamoya disease, DTI-ALPS was more consistently associated with ...

A Danish cohort study of 601 patients finds that MRI without gadolinium-based contrast agents detects intracranial tumors ...

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved ...

Dominic Gillen has been fighting for years to get his son access to medical marijuana in Nebraska. He believes it could help ...

Somewhere in South Carolina, there’s a small town quietly doing something remarkable: making your dollar stretch so far it ...

Just because a researcher is pursuing a specific hypothesis does not necessarily mean they are rejecting others. Nevertheless ...

GSK presents first global data for Ris-Rez in extensive-stage small cell lung cancer. 61% overall response rate in phase Ib trial; Results buil ...

This week, topics ranged from brain signals and immune cells to gene delivery therapies. All of these are summaries of ...

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor ...

Optogenetic therapy improved clinically meaningful light sensitivity in 6 of 10 people with advanced retinitis pigmentosa in an early-stage clinical study.